AstraZeneca to Cut 8,000 Jobs Amid Weak Earnings

Celltrion updates strategy for potential Trump reciprocal tariffs on pharmaceuticals

Biopharma groups seek changes to FDA’s innovative manufacturing strategy

Sanofi CD38 antibody delivers in phase 3 trial

Pfizer to let go of 791 employees at NJ site